NeoPharm CO., LTD. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	26,825	18,234	11,881	10,883	7,049
Short-Term Investments	114,914	108,290	98,026	102,000	98,000
Trading Asset Securities	-	-	2,083	602.5	-
Cash & Short-Term Investments	141,739	126,524	111,990	113,485	105,049
Cash Growth	12.03%	12.98%	-1.32%	8.03%	9.22%
Accounts Receivable	10,612	10,846	8,555	6,543	7,513
Other Receivables	1,590	1,905	1,809	1,103	514.09
Receivables	12,229	12,762	10,383	7,665	8,045
Inventory	15,577	12,676	10,195	8,749	7,973
Prepaid Expenses	204.16	152.09	461.05	61.34	66.55
Other Current Assets	6,712	935.9	1,474	1,309	349.62
Total Current Assets	176,462	153,050	134,502	131,270	121,484
Property, Plant & Equipment	30,184	29,764	29,244	9,341	9,743
Long-Term Investments	1,578	1,310	4,684	6,369	3,559
Other Intangible Assets	1,763	1,951	2,237	1,786	2,055
Long-Term Deferred Tax Assets	407.09	19.41	436.34	135.32	171.21
Other Long-Term Assets	7,105	6,211	6,220	6,328	6,280
Total Assets	217,811	192,440	177,459	155,347	143,408
Accounts Payable	7,658	5,030	6,435	3,703	4,347
Current Portion of Long-Term Debt	-	-	17.68	18.59	19.27
Current Portion of Leases	1,068	500.41	617.57	393.58	437.71
Current Income Taxes Payable	4,042	3,461	3,876	3,778	3,145
Current Unearned Revenue	28.14	27.43	2.24	-	-
Other Current Liabilities	8,223	6,109	5,997	5,244	4,992
Total Current Liabilities	21,020	15,128	16,945	13,137	12,941
Long-Term Leases	847.2	128.99	430.05	-	101.79
Long-Term Unearned Revenue	158.57	-	-	-	-
Pension & Post-Retirement Benefits	-	-	-	-	60.54
Other Long-Term Liabilities	429	298.54	57.73	-	0
Total Liabilities	22,454	15,555	17,433	13,137	13,103
Common Stock	8,014	8,014	4,104	4,104	4,104
Additional Paid-In Capital	41,223	41,223	45,170	45,170	45,170
Retained Earnings	149,083	130,569	113,603	96,106	83,848
Treasury Stock	-2,679	-2,679	-2,679	-2,679	-2,679
Comprehensive Income & Other	-284.38	-242.89	-171.99	-490.33	-138.2
Shareholders' Equity	195,356	176,885	160,026	142,211	130,305
Total Liabilities & Equity	217,811	192,440	177,459	155,347	143,408
Total Debt	1,915	629.4	1,065	412.16	558.77
Net Cash (Debt)	139,824	125,895	110,925	113,073	104,490
Net Cash Growth	11.06%	13.50%	-1.90%	8.21%	13.74%
Net Cash Per Share	8939.41	8048.91	7091.80	7229.16	6680.42
Filing Date Shares Outstanding	15.64	15.64	15.64	15.64	15.64
Total Common Shares Outstanding	15.64	15.64	15.64	15.64	15.64
Working Capital	155,442	137,922	117,558	118,133	108,543
Book Value Per Share	12489.82	11308.86	10231.02	9092.03	8330.85
Tangible Book Value	193,593	174,934	157,789	140,424	128,250
Tangible Book Value Per Share	12377.11	11184.13	10088.01	8977.82	8199.46
Land	8,554	8,554	8,554	1,202	1,223
Buildings	21,018	20,888	18,345	9,791	9,881
Machinery	10,201	9,508	8,214	6,086	6,043
Construction In Progress	273.19	273.19	1,686	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.